Form 4 for REPL Replimune Group, Inc.
Accepted 2021-07-22 00:00:00 ET · period of report 2021-07-20 · accession 0001104659-21-095084 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-07-22 | 2021-07-20+ | REPL | Esposito Pamela | Chief Business Off | S - Sale+OE | $33.14 | -17.4K | 210.2K | -8% | -$576.6K |
| DM | 2021-07-22 | 2021-07-20+ | REPL | Esposito Pamela | Chief Business Off | M - OptEx | $1.01 | +17.4K | 215.0K | +9% | +$17.6K |
| DM | 2021-07-22 | 2021-07-20+ | REPL | Esposito Pamela | Chief Business Off | M - OptEx | $0.00 | -17.4K | 51.2K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-21 | S | D | 12,538 | $33.17 | 210,159 | D | — | — | (F2) Following the sales reported on this Form 4, the reporting person continues to beneficially own 210,159 shares of the Issuer's common stock. The reporting person also holds options to acquire an aggregate of 488,102 shares of the Issuer's common stock, 324,649 of which are exercisable as of the date hereof. Due to scrivener's error, footnote 2 of the Form 4 filed on behalf of the reporting person on July 19, 2021 inadvertently overstated the number of options held by the Reporting Person following the transaction reported therein. The amounts stated in this footnote 2 set forth the correct number of options held by the Reporting Person following the transaction reported herein. |
| 2 | Common | Common Stock | 2021-07-21 | M | A | 12,538 | $1.01 | 222,697 | D | — | — | |
| 3 | Common | Common Stock | 2021-07-20 | M | A | 4,862 | $1.01 | 215,021 | D | — | — | |
| 4 | Common | Common Stock | 2021-07-20 | S | D | 4,862 | $33.05 | 210,159 | D | — | — | |
| 5 | Derivative | Employee Stock Option (right to buy) | 2021-07-20 | M | D | 4,862 | $0.00 | 63,741 | D | $1.01 · — to 2025-11-01 | 4,862 Common Stock | (F3) The reporting person was granted an option to purchase 149,203 shares of the Issuer's common stock on November 1, 2015. All of the shares underlying such stock option have vested and are exercisable as of the date hereof. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2021-07-21 | M | D | 12,538 | $0.00 | 51,203 | D | $1.01 · — to 2025-11-01 | 12,538 Common Stock | (F3) The reporting person was granted an option to purchase 149,203 shares of the Issuer's common stock on November 1, 2015. All of the shares underlying such stock option have vested and are exercisable as of the date hereof. |